Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytokinetics (CYTK) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Cytokinetics (CYTK) over the last 14 years, with Q3 2024 value amounting to 0.38%.

  • Cytokinetics' Return on Capital Employed rose 3400.0% to 0.38% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.38%, marking a year-over-year increase of 3400.0%. This contributed to the annual value of 0.61% for FY2023, which is 2200.0% down from last year.
  • Latest data reveals that Cytokinetics reported Return on Capital Employed of 0.38% as of Q3 2024, which was up 3400.0% from 0.48% recorded in Q2 2024.
  • Over the past 5 years, Cytokinetics' Return on Capital Employed peaked at 0.2% during Q4 2020, and registered a low of 0.73% during Q4 2023.
  • Over the past 5 years, Cytokinetics' median Return on Capital Employed value was 0.34% (recorded in 2022), while the average stood at 0.4%.
  • In the last 5 years, Cytokinetics' Return on Capital Employed tumbled by -4700bps in 2023 and then surged by 3400bps in 2024.
  • Quarter analysis of 5 years shows Cytokinetics' Return on Capital Employed stood at 0.2% in 2020, then fell by -23bps to 0.24% in 2021, then crashed by -38bps to 0.34% in 2022, then tumbled by -116bps to 0.73% in 2023, then surged by 48bps to 0.38% in 2024.
  • Its Return on Capital Employed was 0.38% in Q3 2024, compared to 0.48% in Q2 2024 and 0.68% in Q1 2024.